One nice little detail is the pick-up of the Chinese rights from Nova Vita. On top of the European, USA & Canada rights.
Revenue targets $5-7.5 mil PA by 2010 - and thats on top of Termilone revenues kicking in 2008-2009.
- Forums
- ASX - By Stock
- BPO
- best news bioprospect
best news bioprospect, page-5
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BPO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online